• I-SPY Phase 1

    A Phase Ib clinical trial designed to decrease the amount of time required to collect drug safety data for entry into I-SPY 2.

  • I-SPY 2

    A Phase II neoadjuvant clinical trial designed to decrease the amount of time required to collect drug efficacy data.

  • I-SPY 3

    An international confirmatory Phase III neoadjuvant clinical trial for successful I-SPY 2 agents.

  • I-SPY 2 PATIENT SITE

    Information for interested participants in the I-SPY 2 Clinical Trial.

Two I-SPY 2 Efficacy Papers released in the New England Journal of Medicine

July 6th, 2016
read more
THE I-SPY TRIALS ARE AN UNPRECEDENTED AND STREAMLINED APPROACH TO CLINICAL TRIAL DESIGN
Using breast cancer treatment as a model - the I-SPY TRIALs aim to significantly reduce the cost, time, and number of patients required to bring new drugs to patients who need them.